An update on the management of antiphospholipid syndrome

M Rodziewicz, DP D'Cruz - Therapeutic Advances in …, 2020 - journals.sagepub.com
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by
recurrent venous or arterial thrombosis with or without pregnancy morbidity in the presence …

Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies

C Comarmond, P Cacoub - Autoimmunity Reviews, 2013 - Elsevier
Antiphospholipid syndrome (APS) is characterized by recurrent thrombosis and pregnancy
morbidity in association with the persistent presence of circulating antiphospholipid …

Antiphospholipid syndrome: state of the art of clinical management

L Depietri, MR Veropalumbo, MC Leone… - … Drugs and Therapy, 2023 - Springer
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder clinically
characterized by recurrent arterial and venous thrombosis and/or pregnancy morbidity in the …

Immunosuppressive treatment in antiphospholipid syndrome: is it worth it?

I Mormile, F Granata, A Punziano, A de Paulis… - Biomedicines, 2021 - mdpi.com
The antiphospholipid syndrome (APS) is characterized by the development of venous and/or
arterial thrombosis and pregnancy morbidity in patients with persistent antiphospholipid …

Management of antiphospholipid syndrome

N Del Papa, N Vaso - Therapeutic advances in …, 2010 - journals.sagepub.com
The antiphospholipid syndrome (APS) is an autoimmune disorder presenting with tissue
injury in various organs related to large-or small-vessel thrombosis associated with …

Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future

AA Mehdi, I Uthman… - European journal of clinical …, 2010 - Wiley Online Library
Eur J Clin Invest 2010; 40 (5): 451–464 Abstract Background Antiphospholipid syndrome
(APS) is a systemic autoimmune vascular disease characterized by recurrent thrombotic …

The treatment of anti-phospholipid syndrome: a comprehensive clinical approach

CB Chighizola, L Andreoli, M Gerosa, A Tincani… - Journal of …, 2018 - Elsevier
Anti-phospholipid syndrome (APS) is an acquired pro-thrombotic autoimmune disease that
predisposes to thrombotic events and/or obstetric complications, in the persistent presence …

Current treatment of antiphospholipid syndrome: lights and shadows

G Espinosa, R Cervera - Nature Reviews Rheumatology, 2015 - nature.com
For patients with antiphospholipid syndrome (APS), the consensus is to treat those who
develop thrombosis with long-term oral anticoagulation therapy and to prevent obstetric …

Management of thrombotic antiphospholipid syndrome

CB Chighizola, MG Raimondo… - Seminars in thrombosis …, 2018 - thieme-connect.com
Persistent serum positivity for antiphospholipid antibodies (aPL) is required to diagnose
antiphospholipid syndrome (APS), an autoimmune disease characterized by recurrent …

Management of refractory anti-phospholipid syndrome

T Scoble, S Wijetilleka, MA Khamashta - Autoimmunity reviews, 2011 - Elsevier
Anti-phospholipid syndrome (APS) is an autoimmune prothrombotic disorder characterised
by the predisposition to venous and/or arterial thrombosis and obstetric morbidity …